Filing Flows › Industries › Orthopedic, Prosthetic & Surgical Appliances & Supplies › Capital spending and supply chain
Orthopedic, Prosthetic & Surgical Appliances & Supplies: capital spending and supply chain
SIC 3842 · 20 companies with filed cash-flow statements
Analysis
20 companies in Orthopedic, Prosthetic & Surgical Appliances & Supplies (SIC 3842) spent $1.8B on capital projects over their latest twelve months, 17% of the $10.3B their operations generated; the three largest spenders — ISRG, STE, EW — account for 63%.
Capital spending is 4.2% of the industry's $43.3B of annual revenue.
By the industry's asset mix most of it goes to equipment (51%); about $239M is imported.
The largest supplier of that spending is manufacturing structures ($207M).
Its largest supplying industries, by the input-output tables: imports ($1.8B), professional and commercial equipment and supplies ($896M), plastics packaging materials and unlaminated film and sheet manufacturing ($571M).
Charts
Capital spending by company
| Company | Capital spending | Operating cash flow | Capex / OCF | Period |
|---|---|---|---|---|
| ISRG Intuitive Surgical | $492M | $4.1B | 12% | TTM to Q3 2026 |
| STE Steris | $352M | $1.3B | 27% | TTM to Q2 FY27 |
| EW Edwards Lifesciences | $293M | $1.7B | 17% | TTM to Q3 2026 |
| ZBH Zimmer Biomet Holdings | $241M | $1.9B | 13% | TTM to Q3 2026 |
| ENOV Enovis | $189M | $259M | 73% | TTM to Q3 2026 |
| ALGN Align Technology | $147M | $750M | 20% | TTM to Q3 2026 |
| MSA MSA Safety | $53.7M | $376M | 14% | TTM to Q3 2026 |
| CDRE Cadre Holdings | $12.5M | $88.8M | 14% | TTM to Q3 2026 |
| ESTA Establishment Labs Holdings | $8.2M | −$13.4M | — | TTM to Q3 2026 |
| INGN Inogen | $2.5M | −$2.5M | — | TTM to Q2 2026 |
| AVR Anteris Technologies Global | $2.0M | −$86.3M | — | TTM to Q2 2026 |
| MYO Myomo | $1.2M | −$7.1M | — | TTM to Q2 2026 |
| SMTI Sanara MedTech | $1.2M | $5.7M | 21% | TTM to Q2 2026 |
| APT Alpha Pro Tech | $625K | $6.5M | 10% | TTM to Q2 2026 |
| COCH Envoy Medical | $205K | −$22.2M | — | TTM to Q3 2026 |
| LGMK LogicMark | $128K | −$4.0M | — | TTM to Q2 2026 |
| FEED ENvue Medical | $95K | −$11.6M | — | TTM to Q2 2026 |
| LFWD Lifeward | $19K | −$17.1M | — | TTM to Q2 2026 |
| MLSS Milestone Scientific | $15K | −$643K | — | TTM to Q2 2026 |
| LAKE Lakeland Industries | −$25K | −$693K | — | TTM to Q2 FY27 |
Customers and suppliers named in annual reports
| Supplier | Customer | Share of supplier revenue | Evidence | Source |
|---|---|---|---|---|
| INGN | Medicare & Medicaid | 68% | Stated in 10-K (sentence) | filing |
| UFPT | ISRG | 22% | Stated in 10-K (sentence) | filing |
| MYO | Medicare & Medicaid | 54% | Stated in 10-K (sentence) | filing |
| NDAQ | FEED | — | Stated in 10-K (named, share not stated) | filing |
| UPS | ALGN | — | Stated in 10-K (named, share not stated) | filing |
| AVTR | ESTA | — | Stated in 10-K (named, share not stated) | filing |
The interactive money flow: switch views, follow each dollar →
Evidence grades: A filed figure · B computed from filed figures · C industry average (BEA input-output and fixed-asset tables) applied to filed figures. Estimates are not the companies’ own records. Not investment advice.